Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

FRANKLIN, Tenn., May 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, Scott J. Leffler, will present at the Bank of America 2023 Healthcare Conference on Thursday, May 11, 2023, at 1:40 p.m. Eastern Time.

Clover Health to Present at Bank of America 2023 Healthcare Conference on May 11, 2023

FRANKLIN, Tenn., April 24, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that the Company has reached an agreement to resolve the securities class action captioned Bond v. Clover Health Investments, Corp. et al., Case No. 3:21-CV-00096 (M.D. Tenn.) (the “securities class action”), which was filed in the wake of its de-SPAC transaction. The proposed settlement contains no admission of liability or wrongdoing by any of the defendants, including the Company, and is subject to definitive documentation and final court approval.

Clover Health Announces Agreement to Settle Securities Class Action Litigation

Net annualized savings from initiatives expected to be approximately $30 million beginning in 2024 Net annualized savings from initiatives expected to be approximately $30 million beginning in 2024

Clover Health Announces Business Transformation Initiatives to Accelerate Path to Profitability

Allarity Therapeutics

Novavax

Sangamo Therapeutics

Helius Medical Technologies

Nektar Therapeutics

Vyne Therapeutics

Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing in pharma stocks can also mean heavy expenditures on research and testing for a drug that may not perform as well as scientists hope.

7 Sorry Pharma Stocks to Sell in April Before It's Too Late

FRANKLIN, Tenn., April 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report first quarter 2023 financial results after market close on Tuesday, May 9, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results.

Clover Health to Report First Quarter 2023 Financial Results on May 9, 2023

Hyzon Motors

WeWork

Over the past year, traders have looked for SPACs to sell amid a terrible slump in the sector. But the mood may be changing given the level of destruction across the sector.

3 SPACs to Sell Before They Go Bust in 2023

Social Capital Hedosophia Holdings Corp. III

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Social Capital Hedosophia Holdings Corp. III (“IPOC”) (NYSE: IPOC), now known as Clover Health Investments, Corp. (“Clover Health”) (NASDAQ: CLOV) breached their fiduciary duties to IPOC and its shareholders.

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III's Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV

FRANKLIN, Tenn., March 07, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CFO, Scott J. Leffler, will present at Barclays 2023 Global Healthcare Conference on Tuesday, March 14, 2023, at 4:05 p.m. Eastern Time.

Clover Health to Present at Barclays 2023 Global Healthcare Conference on March 14, 2023

Clover Health (NASDAQ: CLOV ) stock is on the rise Tuesday thanks to the company's earnings report for the fourth quarter of 2022. One of the biggest factors that has investors celebrating is Clover Health's net loss of $84 million.

Can Q4 Results Help Save Clover Health (CLOV) Stock?

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - CEO Scott J. Leffler - CFO Conference Call Participants William Hoover - Canaccord Genuity Benjamin Rossi - Citigroup Kevin Fischbeck - Bank of America Operator Good morning ladies and gentlemen and welcome to the Clover Health Fourth Quarter and Full Year 2022 Earnings Conference Call.

Clover Health Investments, Corp. (CLOV) Q4 2022 Earnings Call Transcript

Q4 2022 Insurance MCR of 92.4% and FY 2022 Insurance MCR of 91.8%

Clover Health Reports Fourth Quarter and Full Year 2022 Financial Results

FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will present at Citi's 2023 Healthcare Conference on Wednesday, March 1, 2023, at 8:45 a.m. Eastern Time.

Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023

FRANKLIN, Tenn., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report fourth quarter and full year 2022 financial results before market open on Tuesday, February 28, 2023. On that day management will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the Company's business and financial results.

Clover Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023

NEW YORK--( BUSINESS WIRE )--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clover Health Investments Corp. (NASDAQ: CLOV) on behalf of long-term stockholders following a class action complaint that was filed against Clover Health on February 5, 2021 with a Class Period from October 6, 2020 and February 4, 2021. Our investigation concerns whether the board of directors of Clover Health have breached their fiduciary duties to the company.

CLOVER HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Clover Health Investments Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

FRANKLIN, Tenn., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today provides a business update and announces partial guidance for full-year 2023.

Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023

Clover Health Investments, Corp. management failed to reach critical profitability milestones, casting a shadow over the feasibility of its business model. Even if Clover Health management achieves its restructuring goals for the DCO segment, it is still far from profitability.

Clover: Stop And Think

FRANKLIN, Tenn., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 4:30 p.m. Eastern Time.

Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

FRANKLIN, Tenn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today issued December Investor Frequently Asked Questions on its investor relations website at https://investors.cloverhealth.com/investor-resources/FAQs. Clover may continue to provide updates to Investor Frequently Asked Questions on its investor website.

Clover Health Issues December 2022 Investor Frequently Asked Questions

FRANKLIN, Tenn., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Anna Loengard, M.D. to the Company's Board of Directors.

Dr. Anna Loengard Joins Clover Health Board of Directors

AMC Preferred Equity Unit

Arrival Group

ATI Physical Therapy

Bird Rides

Party City Holdco

Penny stocks are much riskier than your average investment. After all, you don't typically have a share price below $5 without some problems, be it a failing business plan, poor execution by management, etc.

6 Penny Stocks to Sell Right Now

Bed Bath & Beyond

Bakkt Holdings

FuboTV

MicroVision

Nikola

Skillz

The explosive stock market rally seen on Nov. 10 may have invited some investors to start thinking this downturn is coming to a close. However, before you make the move from “risk-off” to “risk-on,” there are certainly concerns to consider.

7 Penny Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole

The heavy selling pressure might have exhausted for Clover Health Investments, Corp. (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Down 22.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Clover Health Investments, Corp. (CLOV)

Clover Health Investments, Corp. (CLOV) delivered earnings and revenue surprises of 48.39% and 3.34%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Tops Revenue Estimates

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Vivek Garipalli - Chief Executive Officer Andrew Toy - President Scott Leffler - Chief Financial Officer Conference Call Participants Jason Cassorla - Citi Richard Close - Canaccord Genuity Kevin Fischbeck - Bank of America Whit Mayo - SVB Securities. Operator Please stand-by, your program is about to begin.

Clover Health Investments, Corp. (CLOV) Q3 2022 Earnings Call Transcript

Carvana

Opendoor

Peloton

Redfin

Teladoc

Zoom Video

This vicious bear market has spared very few firms in 2022. The S&P 500 has slipped more than 23% so far and it increasingly feels that things are getting worse.

News for Clover Health Investments Stock (CLOV)